The US National Institutes of Health (NIH) has awarded a $9.4m grant to Albert Einstein College of Medicine and Montefiore and the City University of New York (CUNY) research team to lead the study of HIV / AIDS care in Central Africa.
The grant is titled 'Central Africa International Epidemiologic Database to Evaluate Aids' and the research seeks to improve clinical care and health outcomes for patients with HIV in Central Africa.
Go deeper with GlobalData
More than 50,000 HIV-positive children and adults are currently being administered anti-retroviral therapy (ART) as part of the ongoing, five-country observational study, called Central Africa International Epidemiologic Databases to Evaluate AIDS (CA-IeDEA).
The number of clinical sites involved in the study is expected to increase from 15 to 20 as CA-IeDEA expands into more rural areas in the region.
CA-IeDEA is a member of the International Epidemiologic Databases to Evaluate AIDS (IeDEA), which is a global research consortium with seven regional members that partner with each other and external groups, including the World Health Organisation and PEPFAR, to address the questions in HIV / AIDS.
CA-IeDEA currently partners with the governments of Burundi, Cameroon, Rwanda, and the Democratic Republic of Congo, while the Republic of Congo is expected to join soon.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataCA-IeDEA dual principal investigator Dr Denis Nash said: "The IeDEA project is helping us learn more about the models and approaches to HIV care delivery at scale that result in optimal clinical outcomes, such as long-term retention in care and survival.
"Through IeDEA, we are also learning about the ability of HIV clinical sites to diagnose and manage other chronic conditions such as hypertension, diabetes, and mental illness. This is very cutting edge work, with relevance to health systems in Central Africa and beyond."
